Business Description
Fredun Pharmaceuticals Ltd
ISIN : INE194R01017
Compare
Compare
Traded in other countries / regions
539730.India IPO Date
2016-03-21Description
Fredun Pharmaceuticals Ltd is an India based company engaged in the business of pharmaceuticals and healthcare. The company manufactures pharmaceutical formulations, nutraceuticals, herbal supplements, and dietary supplements. In addition, it also manufactures animal healthcare products through its group companies. It sells its products in India and also exports its formulations as branded generics to international countries.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 1.05 | |||||
| Debt-to-EBITDA | 3.05 | |||||
| Interest Coverage | 2.51 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.65 | |||||
| Beneish M-Score | -1.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 30.8 | |||||
| 3-Year EBITDA Growth Rate | 51.3 | |||||
| 3-Year EPS without NRI Growth Rate | 64.7 | |||||
| 3-Year FCF Growth Rate | -77.9 | |||||
| 3-Year Book Growth Rate | 33.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.49 | |||||
| 9-Day RSI | 64.24 | |||||
| 14-Day RSI | 56.56 | |||||
| 6-1 Month Momentum % | -12.14 | |||||
| 12-1 Month Momentum % | -23.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.46 | |||||
| Quick Ratio | 0.61 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 205.27 | |||||
| Days Sales Outstanding | 71.17 | |||||
| Days Payable | 81.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.09 | |||||
| Dividend Payout Ratio | 0.02 | |||||
| 3-Year Dividend Growth Rate | 2 | |||||
| Forward Dividend Yield % | 0.09 | |||||
| 5-Year Yield-on-Cost % | 0.1 | |||||
| 3-Year Average Share Buyback Ratio | -5.6 | |||||
| Shareholder Yield % | -14.14 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 22.06 | |||||
| Operating Margin % | 10.48 | |||||
| Net Margin % | 4.56 | |||||
| FCF Margin % | -2.08 | |||||
| ROE % | 14.59 | |||||
| ROA % | 5.64 | |||||
| ROIC % | 12.43 | |||||
| ROC (Joel Greenblatt) % | 18.53 | |||||
| ROCE % | 29.18 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.49 | |||||
| PE Ratio without NRI | 19.47 | |||||
| Shiller PE Ratio | 46.33 | |||||
| PEG Ratio | 0.63 | |||||
| PS Ratio | 0.89 | |||||
| PB Ratio | 2.64 | |||||
| Price-to-Tangible-Book | 2.67 | |||||
| EV-to-EBIT | 11.6 | |||||
| EV-to-EBITDA | 10.56 | |||||
| EV-to-Revenue | 1.22 | |||||
| EV-to-FCF | -55.32 | |||||
| Price-to-DCF (Earnings Based) | 0.75 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.78 | |||||
| Price-to-Graham-Number | 1.52 | |||||
| Price-to-Net-Current-Asset-Value | 4.46 | |||||
| Earnings Yield (Greenblatt) % | 8.61 | |||||
| FCF Yield % | -2.32 | |||||
| Forward Rate of Return (Yacktman) % | 16.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fredun Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,882.967 | ||
| EPS (TTM) (₹) | 37.68 | ||
| Beta | 2.32 | ||
| Volatility % | 42.95 | ||
| 14-Day RSI | 56.56 | ||
| 14-Day ATR (₹) | 36.41043 | ||
| 20-Day SMA (₹) | 707.0125 | ||
| 12-1 Month Momentum % | -23.88 | ||
| 52-Week Range (₹) | 650 - 1054 | ||
| Shares Outstanding (Mil) | 4.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fredun Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fredun Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fredun Pharmaceuticals Ltd Frequently Asked Questions
What is Fredun Pharmaceuticals Ltd(BOM:539730)'s stock price today?
The current price of BOM:539730 is ₹737.20. The 52 week high of BOM:539730 is ₹1054.00 and 52 week low is ₹650.00.
When is next earnings date of Fredun Pharmaceuticals Ltd(BOM:539730)?
The next earnings date of Fredun Pharmaceuticals Ltd(BOM:539730) is .
Does Fredun Pharmaceuticals Ltd(BOM:539730) pay dividends? If so, how much?
The Dividend Yield %  of Fredun Pharmaceuticals Ltd(BOM:539730) is 0.09% (As of Today), Highest Dividend Payout Ratio of Fredun Pharmaceuticals Ltd(BOM:539730) was 0.13. The lowest was 0.02. And the median was 0.07. The  Forward Dividend Yield % of Fredun Pharmaceuticals Ltd(BOM:539730) is 0.09%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers